Unusual glucuronides

Drug Metabolism and Disposition

Volumn 40, Issue 7, 2012, Pages 1239-1251

  Argikar, Upendra A ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOSULALOL; ASENAPINE; BEVIRIMAT; CARBON; CARVEDILOL; DELTA8 TETRAHYDROCANNABINOL; DISULFIRAM; EBSELEN; ESTRONE; GARENOXACIN; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A9; METOCLOPRAMIDE; MOFEGILINE; PHENYLBUTAZONE; PYRITHIONE; RIMANTADINE; ROPINIROLE; SELENIUM; SERTRALINE; SITAGLIPTIN; SULFINPYRAZONE; SULFUR; TANAPROGET; TESTOSTERONE; TOCAINIDE; UNINDEXED DRUG; VARENICLINE;

AEROBIC METABOLISM; ALCOHOLISM; CARBAMOYLATION; CONJUGATE; DRUG CLEARANCE; DRUG CONJUGATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; ENZYME SPECIFICITY; HUMAN; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; GLUCURONIDES; HUMANS; METABOLIC DETOXICATION, PHASE II;

EID: 84862664760     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.045096     Document Type: Short Survey

References (131)

1. Abdel-aziz MT and Williams KI (1974) Urinary metabolites of mestranol by guinea pigs. J Drug Res 6:195-202.
2. Abolin CR, Tozer TN, Craig JC, and Gruenke LD (1980) C-Glucuronidation of the acetylenic moiety of ethchlorvynol in the rabbit. Science 209:703-704.
3. Adams WJ Jr, Kocsis JJ, and Snyder R (1989) Acute toxicity and urinary excretion of diphenyldiselenide. Toxicol Lett 48:301-310.
4. Adlercreutz H, Fotsis T, Lampe J, Wähälä K, Mäkelä T, Brunow G, and Hase T (1993) Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest Suppl 215:5-18.
5. Adlercreutz H, van der Wildt J, Kinzel J, Attalla H, Wähä lä K, Mäkelä T, Hase T, and Fotsis T (1995) Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52:97-103.
6. Argikar UA, Cloyd JC, Birnbaum AK, Leppik IE, Conway J, Kshirsagar S, Oetting WS, Klein EC, and Remmel RP (2006) Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C19*1/*2 patients. Epilepsy Res 71:54-63.
7. Argikar UA, Gomez J, Ung D, Parkman HP, and Nagar S (2010) Identification of novel metoclopramide metabolites in humans: in vitro and in vivo studies. Drug Metab Dispos 38:1295-1307.
8. Argikar UA, Iwuchukwu OF, and Nagar S (2008) Update on tools for evaluation of uridine diphosphoglucuronosyltransferase polymorphisms. Expert Opin Drug Metab Toxicol 4:879-894.
9. Arnaout WS, Moscioni AD, Felcher AH, Barbour RL, Brown LL, and Demetriou AA (1989) Intraperitoneal transplantation of microcarrier-attached enterocytes in rats. Am J Surg 157: 89-92.
10. Asai A, Nakano T, Takahashi M, and Nagao A (2005) Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J Agric Food Chem 53:7302-7306.
11. Azorin-Ortuno M, Yanez-Gascon MJ, Pallares FJ, Vallejo F, Larrosa M, Garcia-Conesa MT, Tomas-Barberan F, and Espin JC (2010) Pharmacokinetic study of trans-resveratrol in adult pigs. J Agric Food Chem 58:11165-11171.
12. Baer BR, DeLisle RK, and Allen A (2009) Benzylic oxidation of gemfibrozil-1-O-β-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition. Chem Res Toxicol 22:1298-1309.
13. Bakke JE, Huwe JK, Mulford DJ, and Bergman A (1992) Metabolism of 1,2,4-trichlorobenzene in rats: examination of thiol formation. Xenobiotica 22:199-210.
14. Beconi MG, Mao A, Liu DQ, Kochansky C, Pereira T, Raab C, Pearson P, and Lee Chiu SH (2003) Metabolism and pharmacokinetics of a dipeptidyl peptidase IV inhibitor in rats, dogs, and monkeys with selective carbamoyl glucuronidation of the primary amine in dogs. Drug Metab Dispos 31:1269-1277.
15. Berry D and Parke DV (1988) The disposition of feprazone and its hydroxylated metabolite in human volunteers. Xenobiotica 18:857-868.
16. Bevan DR and Sadler VM (1992) Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo[a]pyrene. Carcinogenesis 13:403-407.
17. Billing BH, Cole PG, and Lathe GH (1957) The excretion of bilirubin as a diglucuronide giving the direct van den Bergh reaction. Biochem J 65:774-784.
18. Bock KW, Gschaidmeier H, Seidel A, Baird S, and Burchell B (1992) Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42:613-618.
19. Bock KW, Raschko FT, Gschaidmeier H, Seidel A, Oesch F, Grove AD, and Ritter JK (1999) Mono- and diglucuronide formation from benzo[a]pyrene and chrysene diphenols by AHH-1 cell-expressed UDP-glucuronosyltransferase UGT1A7. Biochem Pharmacol 57:653-656.
20. Boutin JA, Meunier F, Lambert PH, Hennig P, Bertin D, Serkiz B, and Volland JP (1993) In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metab Dispos 21:1157-1166.
21. Bredsdorff L, Nielsen IL, Rasmussen SE, Cornett C, Barron D, Bouisset F, Offord E, and Williamson G (2010) Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects. Br J Nutr 103: 1602-1609.
22. Burchell B, Brierley CH, Monaghan G, and Clarke DJ (1998) The structure and function of the UDP-glucuronosyltransferase gene family. Adv Pharmacol 42:335-338.
23. Burkon A and Somoza V (2008) Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O- conjugated diglucuronides - two novel resveratrol metabolites in human plasma. Mol Nutr Food Res 52:549-557.
24. Bushee JL and Argikar UA (2011) An experimental approach to enhance precursor ion fragmentation for metabolite identification studies: application of dual collision cells in an orbital trap. Rapid Commun Mass Spectrom 25:1356-1362.
25. Clapp JW (1956) A new metabolic pathway for a sulfonamide group. J Biol Chem 223:207-214.
26. Clarke DB, Lloyd AS, Botting NP, Oldfield MF, Needs PW, and Wiseman H (2002) Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C(3)]isoflavone internal standards. Anal Biochem 309:158-172.
27. Coetzee JF, Kruger PB, Albrecht CF, Jahed N, and van Jaarsveld PP (1996) Pharmacokinetic behaviour and cardiovascular effects of intravenously administered hypoxoside and rooperol. Arzneimittelforschung 46:997-1000.
28. Corbic M, Dumont M, De Couët G, and Erlinger S (1982) Choleretic and diuretic properties of dihydroxydibutyl ether in the rat. J Pharmacol Exp Ther 221:769-774.
29. David Josephy P, Peter Guengerich F, and Miners JO (2005) "Phase I and Phase II" drug metabolism: terminology that we should phase out? Drug Metab Rev 37:575-580.
30. Delaforge M, Pruvost A, Perrin L, and André F (2005) Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17β-glucuronide oxidation to 2-hydroxyestradiol- 17β-glucuronide by CYP 2C8. Drug Metab Dispos 33:466-473.
31. Delbressine LP, Funke CW, van Tilborg M, and Kaspersen FM (1990) On the formation of carbamate glucuronides. Xenobiotica 20:133-134.
32. Dieterle W, Faigle JW, Früh F, Mory H, Theoblad W, Alt KO, and Richter WJ (1976) Metabolism of phenylbutazone in man. Arzneimittelforschung 26:572-577.
33. Dieterle W, Faigle JW, and Moppert J (1980) New metabolites of sulfinpyrazone in man. Arzneimittelforschung 30:989-993.
34. Dieterle W, Faigle JW, Mory H, Richter WJ, and Theobald W (1975) Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. Eur J Clin Pharmacol 9:135-145.
35. Dixon R, Hsiao J, Hsu HB, Smulkowski M, Tze-Ming C, Pramanik B, and Morton J (1989) Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog urine. Pharm Res 6:28-32.
36. Dutton GJ and Illing HP (1969) Formation of an S-glucuronide by a UDP-glucuronyltransferase and its hydrolysis by beta-glucuronidase. Biochem J 112:16P.
37. Elvin AT, Keenaghan JB, Byrnes EW, Tenthorey PA, McMaster PD, Takman BH, Lalka D, Manion CV, Baer DT, Wolshin EM, et al. (1980) Tocainide conjugation in humans: novel biotransformation pathway for a primary amine. J Pharm Sci 69:47-49.
38. Ethell BT, Riedel J, Englert H, Jantz H, Oekonomopulos R, and Burchell B (2003) Glucuronidation of HMR1098 in human microsomes: evidence for the involvement of UGT1A1 in the formation of S-glucuronides. Drug Metab Dispos 31:1027-1034.
39. Fisher MB, Paine MF, Strelevitz TJ, and Wrighton SA (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273-297.
40. Gipple KJ, Chan KT, Elvin AT, Lalka D, and Axelson JE (1982) Species differences in the urinary excretion of the novel primary amine conjugate: tocainide carbamoyl O-beta-D-glucuronide. J Pharm Sci 71:1011-1014.
41. Gordon ER, Chan TH, Samodai K, and Goresky CA (1977) The isolation and further characterization of the bilirubin tetrapyrroles in bile-containing human duodenal juice and dog gall-bladder bile. Biochem J 167:1-8.
42. Gordon ER and Goresky CA (1980) The formation of bilirubin diglucuronide by rat liver microsomal preparations. Can J Biochem 58:1302-1310.
43. Gordon ER, Goresky CA, Chang TH, and Perlin AS (1976) The isolation and characterization of bilirubin diglucuronide, the major bilirubin conjugate in dog and human bile. Biochem J 155:477-486.
44. Gordon ER, Sommerer U, and Goresky CA (1983) The hepatic microsomal formation of bilirubin diglucuronide. J Biol Chem 258:15028-15036.
45. Graf BA, Mullen W, Caldwell ST, Hartley RC, Duthie GG, Lean ME, Crozier A, and Edwards CA (2005) Disposition and metabolism of [2-14C]quercetin- 4′-glucoside in rats. Drug Metab Dispos 33:1036-1043.
46. Gschaidmeier H and Bock KW (1994) Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalysing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene. Biochem Pharmacol 48:1545-1549.
47. Gschaidmeier H, Seidel A, Burchell B, and Bock KW (1995) Formation of mono- and diglucu- ronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 49: 1601-1606.
48. Guillemette C (2003) Pharmacogenomics of human UDP- glucuronosyltransferase enzymes. Pharmacogenomics J 3:136-158.
49. Gunduz M, Argikar UA, Baeschlin D, Ferreira S, Hosagrahara V, and Harriman S (2010) Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies. Drug Metab Dispos 38:361-367.
50. Hakk H, Larsen G, and Feil V (2001) Tissue distribution, excretion, and metabolism of 1,2,7,8-tetrachlorodibenzo-p-dioxin in the rat. Chemosphere 42:975-983.
51. Harvey DJ and Paton WD (1980) Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse. Drug Metab Dispos 8:178-186.
52. Hayakawa H, Fukushima Y, Kato H, Fukumoto H, Kadota T, Yamamoto H, Kuroiwa H, Nishigaki J, and Tsuji A (2003) Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters. Drug Metab Dispos 31:1409-1418.
53. Hong YJ and Mitchell AE (2004) Metabolic profiling of flavonol metabolites in human urine by liquid chromatography and tandem mass spectrometry. J Agric Food Chem 52:6794-6801.
54. Hosoda K, Furuta T, Yokokawa A, and Ishii K (2010) Identification and quantification of daidzein-7-glucuronide-4′-sulfate, genistein-7- glucuronide-4′-sulfate and genistein-4′,7- diglucuronide as major metabolites in human plasma after administration of kinako. Anal Bioanal Chem 397:1563-1572.
55. Jaggi R, Addison RS, King AR, Suthers BD, and Dickinson RG (2002) Conjugation of desmethylnaproxen in the rat - a novel acyl glucuronide-sulfate diconjugate as a major biliary metabolite. Drug Metab Dispos 30:161-166.
56. Jansen PL, Chowdhury JR, Fischberg EB, and Arias IM (1977) Enzymatic conversion of bilirubin monoglucuronide to diglucuronide by rat liver plasma membranes. J Biol Chem 252:2710-2716.
57. Jing J, Ren W, Chen X, Wang Y, Yu Q, Wang G, Davey AK, Wang J, and Jing N (2008) Glucuronide-sulfate diconjugate as a novel metabolite of glycyrrhetic acid in rat bile. Drug Metab Pharmacokinet 23:175-180.
58. Joel SP, Osborne RJ, Nixon NS, and Slevin ML (1985) Morphine-6- glucuronide, an important metabolite. Lancet 1:1099-1100.
59. Kaslander J (1963) Formation of an S-glucuronide from tetraethylthiuram disulfide (Antabuse) in man. Biochim Biophys Acta 71:730-731.
60. Keating KA, McConnell O, Zhang Y, Shen L, Demaio W, Mallis L, Elmarakby S, and Chandrasekaran A (2006) NMR characterization of an S-linked glucuronide metabolite of the potent, novel, nonsteroidal progesterone agonist tanaproget. Drug Metab Dispos 34:1283-1287.
61. Kerdpin O, Elliot DJ, Mackenzie PI, and Miners JO (2006) Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9. Drug Metab Dispos 34: 1950-1953.
62. Kim YC and Matthews HB (1987) Comparative metabolism and excretion of resorcinol in male and female F344 rats. Fundam Appl Toxicol 9:409-414.
63. King AR and Dickinson RG (1991) Studies on the reactivity of acyl glucuronides - I. Phenolic glucuronidation of isomers of diflunisal acyl glucuronide in the rat. Biochem Pharmacol 42:2289-2299.
64. King CD, Rios GR, Green MD, and Tephly TR (2000) UDP- glucuronosyltransferases. Curr Drug Metab 1:143-161.
65. Kirsch M, Korth HG, Sustmann R, and de Groot H (2000) Carbon dioxide but not bicarbonate inhibits N-nitrosation of secondary amines. Evidence for amine carbamates as protecting entities. Chem Res Toxicol 13:451-461.
66. Krieter P, Flannery B, Musick T, Gohdes M, Martinho M, and Courtney R (2004) Disposition of posaconazole following single-dose oral administration in healthy subjects. Antimicrob Agents Chemother 48:3543-3551.
67. Kruger PB, Albrecht CF, Liebenberg RW, and van Jaarsveld PP (1994) Studies on hypoxoside and rooperol analogues from Hypoxis rooperi and Hypoxis latifolia and their biotransformation in man by using high-performance liquid chromatography with in-line sorption enrichment and diode-array detection. J Chromatogr B Biomed Appl 662:71-78.
68. Kumar S, Samuel K, Subramanian R, Braun MP, Stearns RA, Chiu SH, Evans DC, and Baillie TA (2002) Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J Pharmacol Exp Ther 303:969-978.
69. Leung JW, Liu YL, Leung PS, Chan RC, Inciardi JF, and Cheng AF (2001) Expression of bacterial beta-glucuronidase in human bile: an in vitro study. Gastrointest Endosc 54:346-350.
70. Levy S, Yagen B, and Mechoulam R (1978) Identification of a C-glucuronide of delta6- tetrahydrocannabinol as a mouse liver conjugate in vivo. Science 200:1390-1392.
71. Lilienblum W, Bock-Hennig BS, and Bock KW (1985) Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol Pharmacol 27:451-458.
72. Lind C (1985) Formation of benzo[a]pyrene-3,6-quinol mono- and diglucuronides in rat liver microsomes. Arch Biochem Biophys 240:226-235.
73. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685.
74. Mackenzie PI, Gregory PA, Gardner-Stephen DA, Lewinsky RH, Jorgensen BR, Nishiyama T, Xie W, and Radominska-Pandya A (2003) Regulation of UDP glucuronosyltransferase genes. Curr Drug Metab 4:249-257.
75. MacKenzie PI, Rogers A, Elliot DJ, Chau N, Hulin JA, Miners JO, and Meech R (2011) The novel UDP glycosyltransferase 3a2: cloning, catalytic properties and tissue distribution. Mol Pharmacol 79:472-478.
76. Mackenzie PI, Rogers A, Treloar J, Jorgensen BR, Miners JO, and Meech R (2008) Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. J Biol Chem 283:36205-36210.
77. Martin IJ, Lewis RJ, Bonnert RV, Cage P, and Moody GC (2003) NMR identification of an S-linked glucuronide of a triazole thione formed in vitro. Drug Metab Dispos 31:694-696.
78. McDonagh AF and Lightner DA (1994) Hepatic uptake, transport and metabolism of alkylated bilirubins in Gunn rats and Sprague-Dawley rats. Cell Mol Biol 40:965-974.
79. Melet A, Marques-Soares C, Schoch GA, Macherey AC, Jaouen M, Dansette PM, Sari MA, Johnson EF, and Mansuy D (2004) Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants. Biochemistry 43: 15379-15392.
80. Miao XS, Zhong C, Wang Y, Savage RE, Yang RY, Kizer D, Volckova E, Ashwell MA, and Chan TC (2009) In vitro metabolism of beta-lapachone (ARQ 501) in mammalian hepatocytes and cultured human cells. Rapid Commun Mass Spectrom 23:12-22.
81. Mitoma C, Steeger T, Rogers J, Thomas D, and Wedig JH (1983) Metabolic disposition of pyrithiones. Fundam Appl Toxicol 3:256-263.
82. Morrow JS, Keim P, and Gurd FR (1974) CO2 adducts of certain amino acids, peptides, and sperm whale myoglobin studied by carbon 13 and proton nuclear magnetic resonance. J Biol Chem 249:7484-7494.
83. Mullen W, Archeveque MA, Edwards CA, Matsumoto H, and Crozier A (2008) Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem 56:11157-11164.
84. Müller A, Gabriel H, Sies H, Terlinden R, Fischer H, and Römer A (1988) A novel biologically active selenooorganic compound-VII. Biotransformation of Ebselen in perfused rat liver. Biochem Pharmacol 37:1103-1109.
85. Murai T, Iwabuchi H, and Ikeda T (2005) Repeated glucuronidation at one hydroxyl group leads to structurally novel diglucuronides of steroid sex hormones. Drug Metab Pharmacokinet 20:282-293.
86. Murai T, Samata N, Iwabuchi H, and Ikeda T (2006) Human UDP-glucuronosyltransferase, UGT1A8, glucuronidates dihydrotestosterone to a monoglucuronide and further to a structurally novel diglucuronide. Drug Metab Dispos 34:1102-1108.
87. Murai T, Yamamura N, Nitanai T, Samata N, Takei M, Iwabuchi H, Tanaka K, Mikamoto K, and Ikeda T (2008) Isolation and identification of diglucuronides of some endogenous steroids in dogs. Drug Metab Dispos 36:368-374.
88. Mutlib AE, Chen H, Nemeth G, Gan LS, and Christ DD (1999) Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz. Drug Metab Dispos 27:1045-1056.
89. Nakaoka M (1990) Kinetic characteristics of UDP-glucuronosyltransferases towards a dithiol metabolite of malotilate in hepatic microsomes of rats and rabbits. Xenobiotica 20:619-627.
90. Nakaoka M, Suzuki W, and Hakusui H (1990) Identification of a dithiol intermediate metabolite of malotilate in rats. Xenobiotica 20:91-98.
91. Newburger J, Castracane VD, Moore PH Jr, Williams MC, and Goldzieher JW (1983) The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. Am J Obstet Gynecol 146:80-87.
92. Nishiyama T, Kobori T, Arai K, Ogura K, Ohnuma T, Ishii K, Hayashi K, and Hiratsuka A (2006) Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone. Arch Biochem Biophys 454:72-79.
93. O'Donnell JP, Khosla NB, and Dalvie DK (1998) Metabolism of droloxifene in the CD-1 mouse, Fischer-344 rat and cynomolgus monkey. Xenobiotica 28:153-166.
94. Obach RS, Cox LM, and Tremaine LM (2005) Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos 33:262-270.
95. Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, and Coe JW (2006) Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos 34:121-130.
96. Ogilvie BW, Zhang D, Li W, Rodrigues AD, Gipson AE, Holsapple J, Toren P, and Parkinson A (2006) Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions. Drug Metab Dispos 34:191-197.
97. Ohyama K, Maki S, Sato K, and Kato Y (2004) In vitro metabolism of [14C]methoxychlor in rat, mouse, Japanese quail and rainbow trout in precision-cut liver slices. Xenobiotica 34:741-754.
98. Ohyama K, Maki S, Sato K, and Kato Y (2005) Comparative in vitro metabolism of methoxychlor in male and female rats: metabolism of demethylated methoxychlor metabolites by precision-cut rat liver slices. Xenobiotica 35:683-695.
99. Okerholm RA, Keeley FJ, Peterson FE, and Glazko AJ (1976) The metabolism of gemfibrozil. Proc R Soc Med 69 (Suppl 2):11-14.
100. Peffer RC, Campbell DD, and Ritter JC (1991) Metabolism of the thiocarbamate herbicide SUTAN in rats. Xenobiotica 21:1139-1152.
101. Peters WH, Jansen PL, and Nauta H (1984) The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J Biol Chem 259:11701-11705.
102. Pritchett JJ, Kuester RK, and Sipes IG (2002) Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab Dispos 30:1180-1185.
103. Ramji JV, Keogh JP, Blake TJ, Broom C, Chenery RJ, Citerone DR, Lewis VA, Taylor AC, and Yeulet SE (1999) Disposition of ropinirole in animals and man. Xenobiotica 29:311-325.
104. Remmel RP, Nagar S, and Argikar UA (2007) Conjugative metabolism of drugs, in Drug Metabolism in Drug Design and Development (Zhang D, Zhu M, and Humphreys WG eds), pp 609, Wiley-Interscience, John Wiley and Sons, Inc., Hoboken.
105. Remmel RP, Zhou J, and Argikar UA (2008) UDP-glucuronosyl transferases, in Drug-Drug Interactions (Rodrigues DA ed), pp 744, Informa Health Care, New York.
106. Remmel RP, Zhou J, and Argikar UA (2009) Uridine diphospho glucuronosyl transferases, in Handbook of Drug Metabolism (Pearson P and Wienkers L eds), pp 630, Informa Health Care, New York.
107. Ronfeld RA, Wolshin EM, and Block AJ (1982) On the kinetics and dynamics of tocainide and its metabolites. Clin Pharmacol Ther 31:384-392.
108. Schaefer WH (1992) Formation of a carbamoyl glucuronide conjugate of carvedilol in vitro using dog and rat liver microsomes. Drug Metab Dispos 20:130-133.
109. Schmid R (1957) Some aspects of bile pigment metabolism. Clin Chem 3:394-400.
110. Shaffer CL, Gunduz M, O'Connell TN, Obach RS, and Yee S (2005) Biotransformation of a GABAA receptor partial agonist in Sprague-Dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolites. Drug Metab Dispos 33:1688-1699.
111. Shattuck KE, Radominska-Pyrek A, Zimniak P, Adcock EW, Lester R, and St Pyrek J (1986) Metabolism of 24-norlithocholic acid in the rat: formation of hydroxyl- and carboxyl-linked glucuronides and effect on bile flow. Hepatology 6:869-873.
112. Smith JE, Ross D, Graham AB, and Skellern GG (1992) Isolation and characterization of the S-glucuronide of 4-nitrothiophenol formed by microsomal glucuronyl transferase. J Pharm Biomed Anal 10:461-463.
113. Sorensen BK, Link JT, von Geldern T, Emery M, Wang J, Hickman B, Grynfarb M, Goos- Nilsson A, and Carroll S (2003) An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist. Bioorg Med Chem Lett 13:2307-2310.
114. Straub K, Davis M, and Hwang B (1988) Benzazepine metabolism revisited. Evidence for the formation of novel amine conjugates. Drug Metab Dispos 16:359-366.
115. Suzuki KT, Kurasaki K, Okazaki N, and Ogra Y (2005) Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes. Toxicol Appl Pharmacol 206:1-8.
116. Tjernberg A, Edlund PO, and Norén B (1998) Screening of eltanolone metabolites in dog urine by anion-exchange/reversed-phase liquid chromatography and mass spectrometry. J Chromatogr B Biomed Sci Appl 715:395-407.
117. Trapnell CB, Klecker RW, Jamis-Dow C, and Collins JM (1998) Glucuronidation of 3′-azido- 3′-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 42:1592-1596.
118. Tremaine LM, Stroh JG, and Ronfeld RA (1989) Characterization of a carbamic acid ester glucuronide of the secondary amine sertraline. Drug Metab Dispos 17:58-63.
119. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616.
120. Vincent SH, Reed JR, Bergman AJ, Elmore CS, Zhu B, Xu S, Ebel D, Larson P, Zeng W, Chen L, et al. (2007) Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans. Drug Metab Dispos 35:533-538.
121. Wen Z, Martin DE, Bullock P, Lee KH, and Smith PC (2007) Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences. Drug Metab Dispos 35:440-448.
122. Williams RT (1947) Detoxication Mechanisms. John Wiley and Sons, Inc., New York.
123. Wrobel K, Wrobel K, Kannamkumarath SS, and Caruso JA (2003) Identification of selenium species in urine by ion-pairing HPLC-ICP-MS using laboratory-synthesized standards. Anal Bioanal Chem 377:670-674.
124. Yagen B, Levy S, Mechoulam R, and Ben-Zvi Z (1977) Synthesis and enzymatic formation of a C-glucuronide of delta6-tetrahydrocannabinol. J Am Chem Soc 99:6444-6446.
125. Yamaguchi H, Kubo J, Sekine K, Naruchi T, Hashimoto Y, and Kato R (1979) Metabolites of feprazone in man. Drug Metab Dispos 7:340-344.
126. Yasuda Y, Shindo T, Mitani N, Ishida N, Oono F, and Kageyama T (1982) Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans. J Pharm Sci 71:565-572.
127. Yeh SY, Gorodetzky CW, and Krebs HA (1977) Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans. J Pharm Sci 66:1288-1293.
128. Yi P, Hadden CE, Annes WF, Jackson DA, Peterson BC, Gillespie TA, and Johnson JT (2007) The disposition and metabolism of naveglitazar, a peroxisome proliferator-activated receptor alpha-gamma dual, gamma-dominant agonist in mice, rats, and monkeys. Drug Metab Dispos 35:51-61.
129. Zhang D, Raghavan N, Wang L, Xue Y, Obermeier M, Chen S, Tao S, Zhang H, Cheng PT, Li W, et al. (2011) Plasma stability-dependent circulation of acyl glucuronide metabolites in humans: how circulating metabolite profiles of muraglitazar and peliglitazar can lead to misleading risk assessment. Drug Metab Dispos 39:123-131.
130. Zhao Z, Egashira Y, and Sanada H (2003) Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic acid. J Nutr 133:1355-1361.
131. Zhou J, Tracy TS, and Remmel RP (2010) Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1. Drug Metab Dispos 38:1907-1911.